Emmanuel van der Schueren

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

J.A. van Dongen, Harry Bartelink, Ian S. Fentiman et al. · European Journal of Cancer · 1992 · 272 citations

Medicine, Oncology, Surgery +17

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987

M Tubiana, M. Henry‐Amar, Patrice Carde et al. · Blood · 1989 · 261 citations · Full text

Medicine, Oncology, Hematologic Oncology +8

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM)

Geertjan van Tienhoven, Adri C. Voogd, Johannes L. Peterse et al. · European Journal of Cancer · 1999 · 217 citations

Medicine, Oncology, Surgery +16

Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results

Erik Van Limbergen, A. Rijnders, Emmanuel van der Schueren et al. · Radiotherapy and Oncology · 1989 · 214 citations

Medicine, Oncology, Surgery +17

Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging

Caroline Weltens, Johan Menten, Michel Féron et al. · Radiotherapy and Oncology · 2001 · 185 citations

Medicine, Oncology, Radiology +17